Lately it seems as if specialty drugs are everywhere. While it used to be that only a small number of patients were treated using these expensive drugs, manufacturers are increasingly developing specialty products to treat conditions that affect much
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/05/17/is-high-prescription-drug-spending-becoming-our-new-normal/
Posted
May 17 2016, 07:15 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Quality, Comparative Effectiveness, Featured, Payment Policy, Costs and Spending, Drugs and Medical Technology, FDA, Sovaldi, Big Pharma, specialty drugs, Biosimiliar, PCSK9 inhibitors